Follow
Ryan Ramanujam
Ryan Ramanujam
Verified email at ki.se
Title
Cited by
Cited by
Year
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden
H Westerlind, R Ramanujam, D Uvehag, R Kuja-Halkola, M Boman, ...
Brain 137 (3), 770-778, 2014
2112014
Effect of smoking cessation on multiple sclerosis prognosis
R Ramanujam, AK Hedström, A Manouchehrinia, L Alfredsson, T Olsson, ...
JAMA neurology 72 (10), 1117-1123, 2015
1952015
Importance of early treatment initiation in the clinical course of multiple sclerosis
A Kavaliunas, A Manouchehrinia, L Stawiarz, R Ramanujam, J Agholme, ...
Multiple Sclerosis Journal 23 (9), 1233-1240, 2017
1672017
Age related multiple sclerosis severity score: disability ranked by age
A Manouchehrinia, H Westerlind, E Kingwell, F Zhu, R Carruthers, ...
Multiple Sclerosis Journal 23 (14), 1938-1946, 2017
1272017
IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype
J Mohammadi, R Ramanujam, S Jarefors, N Rezaei, A Aghamohammadi, ...
Journal of clinical immunology 30, 138-143, 2010
792010
Changes to anti-JCV antibody levels in a Swedish national MS cohort
C Warnke, R Ramanujam, T Plavina, T Bergström, S Goelz, ...
Journal of Neurology, Neurosurgery & Psychiatry 84 (11), 1199-1205, 2013
752013
Multidimensional persistence and noise
M Scolamiero, W Chachólski, A Lundman, R Ramanujam, S Öberg
Foundations of Computational Mathematics 17, 1367-1406, 2017
692017
Utilizing twins concordance rates to infer the predisposition to myasthenia gravis
R Ramanujam, R Pirskanen, S Ramanujam, L Hammarström
Twin research and human genetics 14 (2), 129-136, 2011
632011
PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis
AK Lefvert, Y Zhao, R Ramanujam, S Yu, R Pirskanen, L Hammarström
Journal of neuroimmunology 197 (2), 110-113, 2008
622008
Association of pre-disease body mass index with multiple sclerosis prognosis
A Manouchehrinia, AK Hedström, L Alfredsson, T Olsson, J Hillert, ...
Frontiers in neurology 9, 232, 2018
402018
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: a descriptive study of test results
J Link, R Ramanujam, M Auer, M Ryner, S Hässler, D Bachelet, ...
PLoS One 12 (2), e0170395, 2017
372017
Occurrence of anti-drug antibodies against interferon-beta and natalizumab in multiple sclerosis: a collaborative cohort analysis
D Bachelet, S Hässler, C Mbogning, J Link, M Ryner, R Ramanujam, ...
PloS one 11 (11), e0162752, 2016
362016
Concomitant autoimmunity in myasthenia gravis—lack of association with IgA deficiency
R Ramanujam, F Piehl, R Pirskanen, PK Gregersen, L Hammarström
Journal of neuroimmunology 236 (1-2), 118-122, 2011
362011
Programmed death-1: from gene to protein in autoimmune human myasthenia gravis
P Sakthivel, R Ramanujam, XB Wang, R Pirskanen, AK Lefvert
Journal of neuroimmunology 193 (1-2), 149-155, 2008
342008
Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia
C Warnke, T Dehmel, R Ramanujam, C Holmen, N Nordin, K Wolfram, ...
Neurology 83 (23), 2153-2157, 2014
332014
Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study
L Crielaard, A Kavaliunas, R Ramanujam, T Olsson, J Hillert, P Stridh, ...
Journal of Neurology, Neurosurgery & Psychiatry 90 (7), 761-767, 2019
292019
A topological data analysis based classification method for multiple measurements
H Riihimäki, W Chachólski, J Theorell, J Hillert, R Ramanujam
BMC bioinformatics 21 (1), 1-18, 2020
252020
Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort
H Westerlind, K Imrell, R Ramanujam, KM Myhr, EG Celius, HF Harbo, ...
European Journal of Human Genetics 23 (5), 688-692, 2015
252015
Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice
R Jungedal, M Lundkvist, E Engdahl, R Ramanujam, H Westerlind, ...
Multiple Sclerosis Journal 18 (12), 1775-1781, 2012
212012
Accurate classification of secondary progression in multiple sclerosis using a decision tree
R Ramanujam, F Zhu, K Fink, VD Karrenbauer, J Lorscheider, P Benkert, ...
Multiple Sclerosis Journal 27 (8), 1240-1249, 2021
202021
The system can't perform the operation now. Try again later.
Articles 1–20